PATENT CLAIM ANALYSIS

Application Number: 16020346
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-06
Patent Classification: ["424", "009300"]

Abstract:
Provided are novel human tau-specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays, kits, and solid supports related to antibodies specific for tau are also disclosed. The antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for tau targeted immunotherapy and diagnosis, respectively.

Claim (Index 65):
The method of  claim 64 , wherein the pharmaceutical composition is suitable for intravenous or subcutaneous administration.

Metadata:
- Claim Count in Document: 95.0
- Percentile: 94.0
- Lexical Diversity: 1.59574
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14654176', '14532531', '13271118', '15343450', '15005948']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8514581257310364
- 35 USC 102 Novelty (BERT): 0.634672645621795
- Combined Prediction Score: 0.8297795777201123
- Mean Citation Score: 627.1500920000002
- Max Citation Score: 746.3702
- Similarity Product: 535.2340110505819

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test